Your browser doesn't support javascript.
loading
Chronic cough: more than just a persistent cough: a systematic literature review to understand the impact of chronic cough on quality of life.
Bali, Vishal; Adriano, Ada; Byrne, Aidan; Akers, Katherine G; Frederickson, Andrew; Schelfhout, Jonathan.
Afiliación
  • Bali V; Center for Observational and Real-World Evidence (CORE), Merck & Co. Inc, Rahway, NJ, USA. vishal.bali@merck.com.
  • Adriano A; Merck & Co. Inc, 351 N Sumneytown Pike, Mailstop: UG4D-48, North Wales, PA, 19454, USA. vishal.bali@merck.com.
  • Byrne A; Outcomes Research, MSD (UK) Limited, London, UK.
  • Akers KG; Outcomes Research, MSD (UK) Limited, London, UK.
  • Frederickson A; PRECISIONheor, New York, NY, USA.
  • Schelfhout J; PRECISIONheor, New York, NY, USA.
Qual Life Res ; 33(4): 903-916, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38153616
ABSTRACT

PURPOSE:

Chronic cough (CC), defined as a cough persisting ≥ 8 weeks, can have a substantial negative impact on health-related quality of life (HRQoL). This is exacerbated by challenges with timely diagnosis and a lack of approved therapies. A systematic literature review (SLR) was conducted to identify evidence on HRQoL and health state utility values associated with refractory CC or unexplained CC.

METHODS:

Electronic database searches were supplemented with searches of conference proceedings and health technology assessment body websites. Two independent reviewers assessed all citations for inclusion based on predefined inclusion/exclusion criteria. Key inclusion criteria were patient populations with CC and reporting of patient-reported outcomes or utilities using generic or disease-specific measures.

RESULTS:

Following screening, 65 studies were identified for inclusion in the SLR. Of these, 23 studies assessed HRQoL among patients with CC who were not treated or treated with unspecified interventions, and 42 studies in patients who were treated with specified interventions. The studies indicated a substantial decrement to HRQoL as a result of CC, characterized by generic and disease-specific patient-reported outcome measures. HRQoL was impacted across multiple domains, including physical, psychological, and social functioning. The studies also demonstrated the potential for treatments to have a significant positive impact on HRQoL.

CONCLUSIONS:

CC can substantially affect HRQoL in patients, across physical, psychological, and social domains. Although treatments can improve HRQoL in these patients, the available evidence is limited. There remains an unmet need for approved pharmacological treatments to alleviate CC and improve HRQoL for these patients.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Systematic_reviews Idioma: En Revista: Qual Life Res Asunto de la revista: REABILITACAO / TERAPEUTICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos